Asian patients, as in Japanese and Chinese, do live longer. But, these were from India, AND you can see on the
subgroup analysis table that the Asian subgroup had a higher HR number (closer to 1) than the European and
United States patients. If the Asian patients were a factor then their HR number would be smaller, not larger.
In other words, bavi + docetaxel was of more benefit to the US and European patients than to the Asian patients,
contrary to your claim.
"By all means let's be open-minded, but not so open-minded that our brains drop out." - Richard Dawkins